Catalyst Wire Dossier Catalyst Wire Dossier

BR3005-2

· Boryung Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BR3005-2, covering 2024-05-24 to 2024-05-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers [Phase 1]

See pricing